drugset / Trial / NCT06640439

LED Therapy for Third Molar Surgery

NCT06640439

Phase 0 Not yet recruiting 50 enrolled Huashan Hospital
RandomizedParallel-groupTriple-blindTreatment

Summary

LED Therapy for third molar surgery

Timeline

Start
2024-10-14
Primary completion
2025-02-14
Completion
2025-04-14

Drugs

EvaluationDrugModalityDoseRoute
Background CEFACLOR ANHYDROUS Small molecule 0.375 g
Background Ibuprofen Small molecule 0.3 g
Background Metronidazole Small molecule 0.1 g